Fresenius Medical Care AG... (FMS)
NYSE: FMS
· Real-Time Price · USD
25.00
0.13 (0.52%)
At close: Aug 15, 2025, 2:31 PM
Fresenius Medical Care & KGaA Balance Sheet Statement
Financials in EUR. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 1.72B | 1.07B | 1.18B | 1.37B | 1.09B | 1.15B | 1.4B | 1.55B | 1.36B | 1.22B | 1.27B | 1.11B | 1.02B | 1.17B | 1.48B | 1.56B | 1.41B | 1.07B |
Short-Term Investments | 474.97M | n/a | 163.09M | n/a | n/a | n/a | 154.37M | n/a | n/a | n/a | 187.83M | n/a | n/a | n/a | 159.18M | n/a | n/a | n/a |
Long-Term Investments | 1.34B | 666.75M | 1.12B | 690.79M | 647.96M | 615.75M | 1.08B | 705.1M | 696.39M | 798.02M | 1.2B | 767.7M | 734.73M | 798.95M | 786.9M | 742.8M | 708.56M | 726.6M |
Other Long-Term Assets | 213.01M | 1.16B | 720.02M | 1.22B | 1.13B | 1.1B | 681.83M | 1.18B | 1.16B | 1.16B | 702.46M | 1.24B | 1.23B | 1.27B | 1.24B | 1.38B | 1.25B | 1.19B |
Receivables | 3.23B | 3.59B | 3.41B | 3.28B | 4.06B | 4.05B | 3.64B | 3.71B | 3.65B | 4B | 3.72B | 3.97B | 3.8B | 3.89B | 3.58B | 3.45B | 3.53B | 3.89B |
Inventory | 2B | 2.08B | 2.07B | 2.1B | 2.23B | 2.22B | 2.18B | 2.3B | 2.34B | 2.33B | 2.3B | 2.41B | 2.28B | 2.14B | 2.04B | 2.12B | 2.05B | 1.99B |
Other Current Assets | 718.27M | 1.22B | 1.06B | 1.34B | 1.31B | 1.87B | 1.28B | 1.48B | 1B | 1.01B | 682.6M | 1.02B | 996.4M | 838.27M | 672.58M | 867.41M | 827.33M | 832.38M |
Total Current Assets | 8.14B | 7.96B | 7.92B | 8.09B | 8.69B | 9.28B | 8.7B | 9.05B | 8.35B | 8.56B | 8.2B | 8.51B | 8.1B | 8.04B | 7.97B | 8B | 7.81B | 7.79B |
Property-Plant & Equipment | 6.5B | 6.98B | 7.26B | 6.98B | 7.26B | 7.31B | 7.45B | 7.89B | 7.93B | 8.08B | 8.34B | 9.1B | 8.86B | 8.51B | 8.55B | 8.39B | 8.32B | 8.42B |
Goodwill & Intangibles | 14.87B | 15.97B | 16.54B | 15.54B | 16.16B | 16.04B | 16.01B | 16.81B | 16.82B | 16.9B | 17.31B | 18.79B | 17.14B | 16.11B | 15.82B | 15.32B | 14.89B | 15.04B |
Total Long-Term Assets | 23.16B | 24.78B | 25.64B | 24.42B | 25.21B | 25.05B | 25.23B | 26.58B | 26.61B | 26.94B | 27.55B | 29.89B | 27.96B | 26.68B | 26.4B | 25.83B | 25.17B | 25.37B |
Total Assets | 31.29B | 32.74B | 33.57B | 32.51B | 33.9B | 34.34B | 33.93B | 35.63B | 34.96B | 35.5B | 35.75B | 38.41B | 36.07B | 34.72B | 34.37B | 33.83B | 32.99B | 33.16B |
Account Payables | 751.75M | 895.85M | 984.32M | 772M | 784M | 835.41M | 885.15M | 844.77M | 819.21M | 913.57M | 951.58M | 908.92M | 938.79M | 860.27M | 857.53M | 800.47M | 786.85M | 740.87M |
Deferred Revenue | n/a | n/a | 82.17M | n/a | n/a | n/a | 85.82M | n/a | n/a | n/a | 105.72M | n/a | n/a | n/a | 518.03M | n/a | n/a | n/a |
Short-Term Debt | 1.01B | 685.34M | 577.38M | 1.05B | 803M | 904.87M | 944.6M | 1.26B | 1.61B | 1.41B | 1.34B | 641.01M | 1.47B | 1.17B | 1.92B | 2.02B | 2.02B | 1.93B |
Other Current Liabilities | 3.14B | 3.08B | 2.84B | 3.47B | 3.73B | 3.62B | 2.99B | 3.64B | 3.35B | 3.32B | 2.86B | 3.88B | 3.6B | 3.52B | 2.75B | 3.89B | 3.85B | 3.79B |
Total Current Liabilities | 5.66B | 5.45B | 5.66B | 5.89B | 5.94B | 6.2B | 6.11B | 6.62B | 6.62B | 6.49B | 6.47B | 6.36B | 6.88B | 6.38B | 7.26B | 7.49B | 7.42B | 7.24B |
Long-Term Debt | 6.33B | 6.15B | 6.26B | 6.23B | 6.85B | 7.02B | 6.96B | 7.26B | 7B | 7.33B | 7.17B | 8.07B | 7.26B | 7.45B | 6.65B | 6.57B | 6.5B | 6.32B |
Other Long-Term Liabilities | 1.27B | 1.61B | 1.63B | 1.63B | 2.44B | 1.78B | 1.74B | 1.66B | 1.73B | 1.68B | 1.72B | 1.91B | 1.32B | 1.41B | 1.53B | 1.46B | 1.48B | 1.57B |
Total Long-Term Liabilities | 11.3B | 11.78B | 12.14B | 11.83B | 12.77B | 13B | 12.99B | 13.58B | 13.41B | 13.78B | 13.84B | 15.31B | 13.74B | 13.81B | 13.13B | 12.89B | 12.75B | 12.72B |
Total Liabilities | 16.96B | 17.23B | 17.8B | 17.72B | 18.71B | 19.2B | 19.1B | 20.2B | 20.03B | 20.27B | 20.3B | 21.67B | 20.62B | 20.18B | 20.39B | 20.39B | 20.17B | 19.96B |
Total Debt | 11.02B | 10.84B | 11B | 11.23B | 11.78B | 12.06B | 12.08B | 12.97B | 13.07B | 13.27B | 13.21B | 13.79B | 13.66B | 13.34B | 13.32B | 13.23B | 13.12B | 12.9B |
Common Stock | 293.41M | 293.41M | 293.41M | 293.41M | 293.41M | 293.41M | 293.41M | 293.41M | 293.41M | 293.41M | 293.41M | 293.41M | 293.41M | 293.03M | 293M | 292.99M | 292.98M | 292.89M |
Retained Earnings | 11.29B | 11.47B | 11.27B | 11.09B | 10.87B | 11.03B | 10.92B | 10.76B | 10.64B | 10.85B | 10.71B | 10.48B | 10.8B | 11.03B | 10.83B | 10.57B | 10.29B | 10.5B |
Comprehensive Income | -1.66B | -741.33M | -328.55M | -1.14B | -620.46M | -798.77M | -975.17M | -424.13M | -779.54M | -682.02M | -388.47M | 918.77M | 34.26M | -977.45M | -1.31B | -1.52B | -1.84B | -1.68B |
Shareholders Equity | 13.27B | 14.37B | 14.58B | 13.62B | 13.93B | 13.91B | 13.62B | 14.01B | 13.53B | 13.83B | 13.99B | 15.05B | 14.05B | 13.23B | 12.7B | 12.23B | 11.63B | 12B |
Total Investments | 1.81B | 666.75M | 1.29B | 690.79M | 647.96M | 615.75M | 1.23B | 705.1M | 696.39M | 798.02M | 1.39B | 767.7M | 734.73M | 798.95M | 946.09M | 742.8M | 708.56M | 726.6M |